Efficacy of meningococcal vaccine group B OMV against gonorrhoea in young adults: A retrospective case-control study in New Zealand

Trial Profile

Efficacy of meningococcal vaccine group B OMV against gonorrhoea in young adults: A retrospective case-control study in New Zealand

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2017

At a glance

  • Drugs Meningococcal vaccine group B OMV (Primary)
  • Indications Meningococcal group B infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jul 2017 New trial record
    • 14 Jul 2017 Results published in the Internet Document
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top